Importantly, c-MYC acts in concert with Sp1 to down-regulate the expression of tumor suppressor miR-23b in MM and WM cells [128], and miR-23b enforcement dampened in vitro and in vivo MM or WM growth. This evidence concerns the gene MYC and Miyoshi myopathy.